Treatment of chronic suppurative otitis media with topical tobramycin and dexamethasone

Archives of Otolaryngology - Head and Neck Surgery

Volumn 126, Issue 2, 2000, Pages 165-173

  Alper, Cuneyt M ^a   Dohar, Joseph E ^a   Gulhan, Mehmet ^a   Ozunlu, Adnan ^a   Bagger Sjobak, Dan ^b   Hebda, Patricia A ^a   Swarts, J Douglas ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; TOBRAMYCIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; AUDITORY THRESHOLD; CHRONIC OTITIS MEDIA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; ELECTROCOCHLEOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; MALE; MONKEY; NONHUMAN; OTOSCOPY; PERILYMPH; PSEUDOMONAS AERUGINOSA; REMISSION; TREATMENT OUTCOME;

EID: 0033954522     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.126.2.165     Document Type: Article

References (28)

1. Mandel EM, Casselbrant ML, Kurs-Lasky M. Acute otorrhea: bacteriology of a common complication of tympanostomy tubes. Ann Otol Rhinol Laryngol. 1994; 103:713-718.
2. Dohar JE, Garner ET, Nielsen RW, Biel MA, Seidlin M. Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes. Arch Otolaryngol Head Neck Surg. 1999;125:537-545.
3. Kenna MA. Microbiology of chronic suppurative otitis media in children. Ann Otol Rhinol Laryngol. 1988;97(suppl 131):9-10.
4. Dohar JE, Kenna MA, Wadowsky RM. Therapeutic implications in the treatment of aural Pseudomonas infections based on in vitro susceptibility patterns. Arch Otolaryngol Head Neck Surg. 1995;121:1022-1025.
5. Nelson JD. Management of CSOM: a survey of practicing pediatricians. Ann Otol Rhinol Laryngol Suppl. 1988;97(suppl 131):26-28.
6. Lundy LB, Graham MD. Ototoxicity and ototopical medications: a survey of otolaryngologists. Am J Otol. 1993;14:141-146.
7. Matz GJ. Clinical perspectives on ototoxic drugs. Ann Otol Rhinol Laryngol. 1990; 99:39-41.
8. Lind O, Kristiansen B. Deafness after treatment with ear drops containing neomycin, gramicidin, and dexamethasone. ORL J Otorhinolaryngol Relat Spec. 1986; 48:52-54.
9. Linder TE, Zwicky S, Brandle P. Otoxicity of ear drops: a clinical perspective. Am J Otol. 1995;16:653-656.
10. Podoshin L, Fradis M, Ben-David J. Ototoxicity of ear drops in patients suffering from chronic otitis media. J Laryngol Otol. 1989;103:46-50.
11. Griffin WL. A retrospective study of traumatic tympanic membrane perforations in a clinical practice. Laryngoscope. 1979;89:261-282.
12. Esposito S, D'Errico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin. Arch Otolaryngol Head Neck Surg. 1990;116:557-559.
13. Spoendlin H, Brun JP, The block-surface technique for evaluation of cochlear pathology. Arch Otorhinolaryngol. 1974;208:137-145.
14. Parker FL, James GWL. The effect of various topical antibiotic and antibacterial agents on the middle and inner ear of the guinea pig. J Pharm Pharmacol. 1978; 30:236-239.
15. Morizono T, Paparella M, Juhn S. Ototoxicity of propylene glycol in experimental animals. Am J Otolaryngol. 1980;5:393-399.
16. Wright CG, Meyerhoff WL. Ototoxicity of otic drops applied to the middle ear in the chinchilla. Am J Otolaryngol. 1984;5:166-176.
17. Barlow DW, Duckert LG, Kreig CS, Gates GA. Ototoxicity of topical otomicrobial agents. Acta Otolaryngol (Stockh). 1994;115:231-235.
18. Jacob T, Wright CG, Robinson K, Meyerhoff WL. Ototoxicity of topical ticarcillin and clavulanic acid in the chinchilla. Arch Otolaryngol Head Neck Surg. 1995; 121:39-43.
19. Wright CG, Halama AR, Meyerhoff WL. Ototoxicity of an topical preparation in a primate. Am J Otol. 1987;8:56-60.
20. Wright CG, Meyerhoff WL, Halama AR. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987; 8:495-499.
21. Brownlee RE, Hulka GF, Prazma J. Pillsbury HC III Ciprofloxacin: use as a topical otic preparation. Arch Otolaryngol Head Neck Surg. 1992;118:392-396.
22. Dohar JE, Alper CM, Rose EA, et al. Treatment of chronic suppurative otitis media (CSOM) with topical ciprofloxacin. Ann Otol Rhinol Laryngol. 1998;107:865-871.
23. Costerton JW, Lewandowski Z, Caldwell DE, Korber DW, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol. 1995;49:711-745.
24. Fradis M, Brodsky A, Ben-David J, Srungo I, Larboni J, Podoshin L. Chronic otitis media treated topically with ciprofloxacin or tobramycin. Arch Otolaryngol Head Neck Surg. 1997;123:1057-1060.
25. Wintermeyer SM, Hart MC, Nahata MC. Efficacy of ototopical ciprofloxacin in pediatric patients with otorrhea. Otolaryngol Head Neck Surg. 1997;116:450-453.
26. Smith DW, Moody DB, Stebbins WC, Norat MA. Effects of hair cell loss on the frequency selectivity of the patas monkey auditory system. Hear Res. 1987;29: 125-138.
27. English MG, Northern JL, Fria T. Chronic otitis media as a cause of sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 1973;98:18-22.
28. Harada T, Yamasoba T, Yagi M. Sensorineural hearing loss associated with otitis media with effusion. ORL J Otorhinolaryngol Relat Spec. 1992;54:61-65.